Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>FDA fast-tracks approval of a new drug combination for treatment of heart failure; warns about medication errors for two drugs; approves first monoclonal anti-body as second-line treatment for high cholesterol; green lights oral medication for treatment of locally advanced basal cell carcinoma; and approves two new hepatitis C treatments.</p>

FDA Actions